Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Goldenberg

Showing results (171-180 of 296) with videos related to

Pageof 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphyThomas M Cardillo, Habibe Karacay, David M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2005
Clinical-scale radiolabeling of a humanized anticarcinoembryonic antigen monoclonal antibody, hMN-14, with residualizing 131I for use in radioimmunotherapySerengulam V Govindan, Gary L Griffiths, Rhona Stein, et al.
Molecular Cancer Therapeutics|October 29, 2017
Selective and Concentrated Accretion of SN-38 with a CEACAM5-Targeting Antibody-Drug Conjugate (ADC), Labetuzumab Govitecan (IMMU-130)Robert M Sharkey, Serengulam V Govindan, Thomas M Cardillo, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 12, 2014
CD74 interferes with the expression of fas receptor on the surface of lymphoma cellsZuzana Berkova, Shu Wang, Xue Ao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
A novel facile method of labeling octreotide with (18)F-fluorinePeter Laverman, William J McBride, Robert M Sharkey, et al.
Plos One|July 31, 2012
A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitroChien-Hsing Chang, Jorma Hinkula, Meiyu Loo, et al.
Radiology|January 30, 2008
Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse modelRobert M Sharkey, Habibe Karacay, Shankar Vallabhajosula, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2003
Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patientsJeffry A Siegel, Dion Yeldell, David M Goldenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2011
Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclideEric Frampas, Catherine Maurel, Patricia Remaud-Le Saëc, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphomaRobert M Sharkey, Habibe Karacay, Christine R Johnson, et al.
Pageof 30

Showing results (171-180 of 296) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphyThomas M Cardillo, Habibe Karacay, David M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2005
Clinical-scale radiolabeling of a humanized anticarcinoembryonic antigen monoclonal antibody, hMN-14, with residualizing 131I for use in radioimmunotherapySerengulam V Govindan, Gary L Griffiths, Rhona Stein, et al.
Molecular Cancer Therapeutics|October 29, 2017
Selective and Concentrated Accretion of SN-38 with a CEACAM5-Targeting Antibody-Drug Conjugate (ADC), Labetuzumab Govitecan (IMMU-130)Robert M Sharkey, Serengulam V Govindan, Thomas M Cardillo, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 12, 2014
CD74 interferes with the expression of fas receptor on the surface of lymphoma cellsZuzana Berkova, Shu Wang, Xue Ao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
A novel facile method of labeling octreotide with (18)F-fluorinePeter Laverman, William J McBride, Robert M Sharkey, et al.
Plos One|July 31, 2012
A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitroChien-Hsing Chang, Jorma Hinkula, Meiyu Loo, et al.
Radiology|January 30, 2008
Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse modelRobert M Sharkey, Habibe Karacay, Shankar Vallabhajosula, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2003
Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patientsJeffry A Siegel, Dion Yeldell, David M Goldenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2011
Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclideEric Frampas, Catherine Maurel, Patricia Remaud-Le Saëc, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphomaRobert M Sharkey, Habibe Karacay, Christine R Johnson, et al.
Pageof 30